1. Opioid use disorders: HHS needs measures to assess the effectiveness of efforts to expand access to medication-assisted treatment : report to majority leader, U.S. Senate Publication: Washington, DC : United States Government Accountability Office, October 2017 Subject(s): Health Services AccessibilityOpiate Substitution TreatmentOpioid-Related Disorders -- drug therapyOutcome Assessment (Health Care)Community-Institutional RelationsBuprenorphine -- therapeutic useInservice TrainingInsurance CoverageMethadone -- therapeutic useNaloxone -- therapeutic useNaltrexone -- therapeutic usePrescription Drug Diversion -- prevention & controlHumansUnited StatesUnited States. Department of Health and Human Services.
2. Opioid use disorder: developing depot buprenorphine products for treatment Publication: Silver Spring, MD : Center for Drug Evaluation and Research, February 2019 Subject(s): Buprenorphine -- therapeutic useDrug DevelopmentOpioid-Related Disorders -- drug therapyBuprenorphine -- administration & dosageClinical Trials as TopicDelayed-Action PreparationsNarcotic AntagonistsOpiate Substitution TreatmentHumansUnited StatesUnited States. Department of Health and Human Services.United States. Food and Drug Administration.
3. Opioid use decreased in Medicare Part D, while medication-assisted treatment increased Publication: [Washington, D.C.] : U.S. Department of Health and Human Services, Office of Inspector General, July 2019 Subject(s): Analgesics, Opioid -- therapeutic useMedicare Part DOpiate Substitution TreatmentOpioid-Related Disorders -- drug therapyDrug Overdose -- drug therapyDrug Utilization -- trendsForecastingInappropriate PrescribingNaloxone -- therapeutic useState GovernmentHumansUnited States
